Mga Batayang Estadistika
| CIK | 1543637 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Nu-Med Plus, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as speci |
|
| May 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as spec |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 [ ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-54808 NU-MED PLUS, I |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as |
|
| October 30, 2024 |
Completion of Acquisition or Disposition of Assets United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 28, 2024 Nu-Med Plus, Inc. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation (Commission File Numb |
|
| August 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as speci |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54808 CUSIP NUMBER 67021R 10 4 (Check One) [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended June 30, 2024 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11- |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as spec |
|
| May 2, 2024 |
United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 28, 2024 Nu-Med Plus, Inc. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation (Commission File Number |
|
| April 29, 2024 |
United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 25, 2024 Nu-Med Plus, Inc. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation (Commission File Number |
|
| April 29, 2024 |
Share Exchange Agreement with YourSpace America, Inc. dated April 25, 2024* SHARE EXCHANGE AGREEMENT This SHARE EXCHANGE AGREEMENT (the “Agreement”) is made and entered into as of April 25, 2024, by and among Nu-Med Plus, Inc. |
|
| March 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 [ ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-54808 NU-MED PLUS, I |
|
| November 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as speci |
|
| May 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 15, 2023 NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of Incorporation) (Commission File Number) |
|
| May 24, 2023 |
CONFIDENTIAL LETTER OF INTENT FOR THE MERGER OF YOURSPACE AMERICA, INC. INTO NU-MED PLUS, INC. ("LOI") May 15, 2023 1. Parties (a) YourSpace America, Inc. a Delaware corporation with its principal address at 999 Corporate Drive, Suite 100, Ladera Ranch, CA 92694 ("YSI"), or any of YST 's designated subsidiaries (the "Merging Entity"); and (b) Nu-Med Plus, Inc., a Utah corporation with its principa |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as spec |
|
| April 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-54808 NU-MED PLUS |
|
| March 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-54808 NU-MED PLUS, |
|
| February 21, 2023 |
United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 17, 2023 Nu-Med Plus, Inc. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation (Commission File Num |
|
| February 21, 2023 |
February 17, 2023 Securities and Exchange Commission 100 F Street, N.W. Washington, D.C. 20549-7561 Ladies and Gentlemen, We have read the statements of Nu-Med Plus, Inc. relating to the event described under Item 4.01 of Form 8-K dated February 17, 2023 and we agree with such statements as they pertain to our firm. Respectfully, Sadler, Gibb & Associates, LLC Draper, UT S|G Phone: 801-783-2950 | |
|
| November 22, 2022 |
Appendix A NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. |
|
| November 22, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 18, 2022 Nu-Med Plus, Inc. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation (Commission File N |
|
| November 22, 2022 |
United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 18, 2022 Nu-Med Plus, Inc. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation (Commission File Num |
|
| November 22, 2022 |
Appendix A NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. |
|
| November 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54808 CUSIP NUMBER 67021R 10 4 (Check One) [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended September 30, 2022 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on For |
|
| October 21, 2022 |
United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 18, 2022 Nu-Med Plus, Inc. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation (Commission File Numb |
|
| September 13, 2022 |
United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 12, 2022 Nu-Med Plus, Inc. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation (Commission File Nu |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as speci |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as spec |
|
| April 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM 10-K/A (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934?? For the fiscal year ended December 31 , 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934?? For the transition period from to Commission File Number: 0 |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934?? For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934?? For the transition period from to Commission File Number: 000-54808 NU-MED PLUS, |
|
| January 4, 2022 |
8-K 1 form8-kdraft12-31-21.htm CURRENT REPORT ON FORM 8-K DATED DECEMBER 31, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 31, 2021 NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-5 |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ?QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934?? For the quarterly period ended September 30, 2021 ?TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT?? For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as sp |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ?QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934?? For the quarterly period ended June 30, 2021 ?TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT?? For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as specifi |
|
| May 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as spec |
|
| April 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Nu-Med Plus, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 67021R104 (CUSIP Number) Branden T. Burningham, Esq. 2150 South 1300 East, Suite 500 Salt Lake City, UT 84106 (801)-363-7411 (Name, Address and Telephone Number of Person Authorized to Receive N |
|
| March 31, 2021 |
Annual Report - ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED DECEMBER 31, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-54808 NU-MED PLUS, |
|
| November 24, 2020 |
Other Events - CURRENT REPORT ON FORM 8-K DATED NOVEMBER 16, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 16, 2020 NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation (Commission File Num |
|
| November 16, 2020 |
Quarterly Report - QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as |
|
| August 19, 2020 |
Quarterly Report - QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED JUNE 30, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as speci |
|
| August 13, 2020 |
12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54808 CUSIP NUMBER 67021R 10 4 (Check One) [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended June 30, 2020 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on F |
|
| May 14, 2020 |
Quarterly Report - QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED MARCH 31, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as spec |
|
| March 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-54808 NU-MED PLUS, |
|
| November 14, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as |
|
| August 14, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as speci |
|
| May 15, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as spec |
|
| April 1, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-54808 NU-MED PLUS, |
|
| November 19, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as |
|
| November 14, 2018 |
12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54808 CUSIP NUMBER 67021R 10 4 (Check One) [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended September 30, 2018 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report |
|
| August 2, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as speci |
|
| May 11, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as spec |
|
| April 27, 2018 |
Nu-Med Plus Shareholders Re-Elect All 5 Directors at 2018 Shareholder Meeting Salt Lake City, Utah- (Globe Newswire- April24, 2018)- Nu-Med Plus, Inc. |
|
| April 27, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 10, 2018 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| April 3, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-54808 NU-MED PLUS, |
|
| April 2, 2018 |
12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54808 CUSIP NUMBER 67021R 10 4 (Check One) [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended December 31, 2017 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report |
|
| March 23, 2018 |
NUMD / Nu-Med Plus Inc. DEFINITIVE PROXY STATEMENT As filed with the Securities and Exchange Commission on March 22, 2018 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for the use of the Commission only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material Under Rule 14a-12 NU-MED PLUS, INC. |
|
| February 14, 2018 |
1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 13, 2018 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation) (Commission File |
|
| February 14, 2018 |
Nu-Med Plus Announces Keith L Nu-Med Plus Announces Keith L. Merrell as their full-time Chief Financial Officer and Secretary/Treasurer. Salt Lake City, Utah ? (Globe Newswire) ? February 13, 2018) - Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new disruptive technologies in the medical field, announced that Keith L. Merrell has beco |
|
| December 14, 2017 |
1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 16, 2017 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation) (Commission File N |
|
| November 14, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as |
|
| September 20, 2017 |
Converted by EDGARwiz |
|
| September 20, 2017 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 8, 2017 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| August 18, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as speci |
|
| August 14, 2017 |
12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54808 CUSIP NUMBER 67021R 10 4 (Check One) [x] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended June 30, 2017 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on F |
|
| June 28, 2017 |
Nu-Med Plus Inc. Announces Patent Approval Notification For Low Cost Nitric Oxide Technology Nu-Med Plus Inc Nu-Med Plus Inc. Announces Patent Approval Notification For Low Cost Nitric Oxide Technology Salt Lake City, Utah - (Marketwired ? June 27, 2017) - Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced its notification of patent approval for its low cost Nitric Oxide delivery te |
|
| June 28, 2017 |
Regulation FD Disclosure, Financial Statements and Exhibits 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 27, 2017 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 17, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as spec |
|
| May 15, 2017 |
12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54808 CUSIP NUMBER 67021R 10 4 (Check One) [x] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended March 31, 2017 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on |
|
| April 19, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-54808 NU-MED PLUS, |
|
| March 31, 2017 |
12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54808 CUSIP NUMBER 67021R 10 4 (Check One) [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended December 31, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report |
|
| March 28, 2017 |
Nu-Med Plus files 8-K Disclosure Nu-Med Plus files 8-K Disclosure Nu-Med Plus files 8-K Disclosure Salt Lake City, Utah - (Marketwired ? March 28, 2017) - Nu-Med Plus, Inc. |
|
| March 28, 2017 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 16, 2017 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation) (Commission File N |
|
| March 21, 2017 |
1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 16, 2017 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation) (Commission File Num |
|
| March 15, 2017 |
Converted by EDGARwiz |
|
| March 15, 2017 |
Financial Statements and Exhibits, Other Events 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 14, 2017 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation) (Commission File Num |
|
| February 7, 2017 |
NUMD / Nu-Med Plus Inc. / Smith Corporate Services, Inc. - AMENDED SCHEDULE 13-G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1) NU-MED PLUS, INC. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 67021R 104 (CUSIP Number) February 7, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i |
|
| February 2, 2017 |
Converted by EDGARwiz |
|
| February 2, 2017 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 1, 2017 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation) (Commission File N |
|
| January 17, 2017 |
Converted by EDGARwiz (a professional corporation) Lake City. UT 84101 (801) 532-7800 Fax (801) 328-4461 January 17, 2017 U.S.Securities and Exchange Commission 100 E Street Washington, DC 20549- 7561 Ladies and Gentlemen: Re: Nu Med Plus, Inc. Commission File No.000-54808 We have read the statement of Nu-Med Plus, Inc. pertaining to our firm included in Item 4.01 of the Form 8-K dated January l7, |
|
| January 17, 2017 |
Changes in Registrant's Certifying Accountant UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 17, 2017 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or Other Jurisdiction of Incorporation) (Commi |
|
| November 9, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as |
|
| August 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of regis |
|
| August 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of regis |
|
| June 16, 2016 |
Converted by EDGARwiz |
|
| June 16, 2016 |
1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 13, 2016 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as spec |
|
| April 13, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 [ ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-54808 NU-MED PLUS, I |
|
| March 29, 2016 |
12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54808 CUSIP NUMBER 67021R 10 4 (Check One) [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended December 31, 2015 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report |
|
| January 7, 2016 |
Converted by EDGARwiz |
|
| January 7, 2016 |
Changes in Registrant's Certifying Accountant UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 4, 2016 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or Other Jurisdiction of Incorporation) (Commis |
|
| November 24, 2015 |
Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 24, 2015 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or Other Jurisdiction of (Commission File Number) (I.R.S. |
|
| November 23, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as |
|
| November 16, 2015 |
12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54808 CUSIP NUMBER 67021R 10 4 (Check One) [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended September 30, 2015 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report |
|
| August 12, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as speci |
|
| August 4, 2015 |
Nu-Med Plus Announces the Addition of Keith L. Merrell as their Chief Financial Officer. Nu-Med Plus Announces the Addition of Keith L Nu-Med Plus Announces the Addition of Keith L. |
|
| August 4, 2015 |
EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is entered into effective this 31st day of July, 2015, by and between NU-MED PLUS, INC. |
|
| August 4, 2015 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 28, 2015 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or Other Jurisdiction of (Commission File Number) |
|
| August 4, 2015 |
Converted by EDGARwiz |
|
| August 4, 2015 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 28, 2015 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or Other Jurisdiction of (Commission File Numbe |
|
| July 15, 2015 |
Nu-Med Plus, Inc. Selects NT Associates as its’ Strategic Public Relations Partner. Nu-Med Plus, Inc Nu-Med Plus, Inc. Selects NT Associates as its? Strategic Public Relations Partner. Salt Lake City, Utah - (Market wired ? July 14, 2015) - Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has selected New York based corporate advisory firm NT Associates as its strategic public |
|
| July 15, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits United States Securities and Exchange Commission United States Securities and Exchange Commission Washington, D. |
|
| June 18, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits United States Securities and Exchange Commission United States Securities and Exchange Commission Washington, D. |
|
| June 18, 2015 |
Nu-Med Plus, Inc. Selects Affinity Advisors, LLC as their Nu-Med Plus, Inc Nu-Med Plus, Inc. Selects Affinity Advisors, LLC as their Strategic Public Relations Partner. Salt Lake City, Utah - (Market wired ? June 16, 2015) - Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has selected New York based corporate advisory firm Affinity Advisors as its str |
|
| May 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 10-Q 1 numedform10qmarch15.htm QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED MARCH 31, 2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition pe |
|
| April 27, 2015 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 23, 2015 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation) (Commiss |
|
| March 23, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 [ ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-54808 NU-MED PLUS, I |
|
| January 29, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 26, 2015 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other Jurisdiction (Commission File Number of Incorporati |
|
| January 27, 2015 |
Corporate 455 East 500 South Salt Lake City, UT 84111 801.746.3570 Phone 801.355.7126 Fax Lab 1266 South 1380 West Orem, UT 84058 www.Nu-MedPlus.com JANUARY 18, 2015 Dear Shareholder, 2014 has been an inspiring year to remember for Nu-Med Plus. We are eager to share our accomplishments and plans for 2015. There are key products and advances discussed in this letter about the advancement of NU-MED |
|
| January 27, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 23, 2015 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation) (Commission File Num |
|
| November 14, 2014 |
AMENDMENT TO CONSULTING AGREEMENT This Amendment to the Consulting Agreement (?Amendment?), by and between NU-MED PLUS, INC. |
|
| November 14, 2014 |
AMENDMENT TO CONSULTING AGREEMENT This Amendment to the Consulting Agreement (?Amendment?), by and between NU-MED PLUS, INC. |
|
| November 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 10-Q 1 numedform10qsept142.htm QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the trans |
|
| October 1, 2014 |
AMENDMENT CONSULTING AGREEMENT AMENDMENT TO CONSULTING AGREEMENT This Amendment to the Consulting Agreement (“Amendment”), by and between NU-MED PLUS, INC. |
|
| October 1, 2014 |
1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 1, 2014 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| October 1, 2014 |
AMENDMENT CONSULTING AGREEMENT AMENDMENT TO CONSULTING AGREEMENT This Amendment to the Consulting Agreement (“Amendment”), by and between NU-MED PLUS, INC. |
|
| August 11, 2014 |
CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this ?Agreement?) is entered into effective as of the 24th day of May, 2014, by and between NU-MED PLUS, INC. |
|
| August 11, 2014 |
CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this ?Agreement?) is entered into effective as of the 23rd day of May, 2014, by and between NU-MED PLUS, INC. |
|
| August 11, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as speci |
|
| August 11, 2014 |
MEDICAL ADVISOR AGREEMENT THIS MEDICAL ADVISOR AGREEMENT (this “Agreement”) is entered into effective as of the 30th day of May, 2014, by and between NU-MED PLUS, INC. |
|
| July 1, 2014 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 1, 2014 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction (Commission File Number) (IRS Employer ID |
|
| July 1, 2014 | ||
| May 13, 2014 |
EX-10 2 stockpurchaseagreementdschen.htm STOCK PURCHASE AGREEMENT STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into this 18th day of April, 2014, by and among NU-MED PLUS, INC., a Utah corporation (hereinafter referred to as the “Company”) and David Schenk, an individual residing in the state of Utah, (hereinafter referred to as the “Buyer”), on the |
|
| May 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as spec |
|
| March 27, 2014 |
Nu-Med Plus AMENDED ANNUAL REPORT ON FORM 10K/A FOR THE YEAR ENDED DECEMBER 31, 2013 (Annual Report) UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 (Mark One) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 [ ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File |
|
| March 27, 2014 |
AMENDMENT NO AMENDMENT TO PROMISSORY NOTE This Amendment to the Promissory Note (?Amendment?), by and between NU-MED PLUS, INC. |
|
| February 21, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 [ ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-54808 NU-MED PLUS, I |
|
| January 8, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 7, 2014 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction (Commission File Number) (IRS Employer |
|
| January 8, 2014 |
AMENDMENT CONSULTING AGREEMENT AMENDMENT NO AMENDMENT TO CONSULTING AGREEMENT This Amendment to the Consulting Agreement (“Amendment”), by and between NU-MED PLUS, INC. |
|
| November 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as |
|
| October 31, 2013 |
STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into this 28th day of October, 2013, by and among NU-MED PLUS, INC. |
|
| October 31, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 28, 2013 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction (Commission File Number) (IRS Employer |
|
| October 1, 2013 |
SECOND AMENDMENT TO PROMISSORY NOTE This Second Amendment to the Promissory Note (“Amendment”), by and between NU-MED PLUS, INC. |
|
| October 1, 2013 |
EX-10 2 promissorynotescs.htm PROMISSORY NOTE Date: September 27, 2013 Amount: $136,600 (U.S.) NU-MED PLUS, INC. SECURED PROMISSORY NOTE BEARING INTEREST AT 8% PER ANNUM THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE TRANSFERRED O |
|
| October 1, 2013 |
1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 27, 2013 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction (Commission File Number) (IRS Empl |
|
| September 9, 2013 |
EX-10 2 loanagreementrobertsmartsept.htm LOAN AGREEMENT LOAN AGREEMENT THIS LOAN AGREEMENT (this “Agreement”) is made and entered into this 4th day of September, 2013, by and among NU-MED PLUS, INC., a Utah corporation (hereinafter referred to as the “Company”) and Robert Smart, an individual residing in the state of Utah, (hereinafter referred to as the “Lender”), on the following: Premises A. Le |
|
| September 9, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 3, 2013 (Date of Report: Date of earliest event reported) NU-MED PLUS, INC. (Exact name of registrant as specified in its charter) Utah 000-54808 45-3672530 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| September 5, 2013 |
NUMD / Nu-Med Plus Inc. / Tait Thomas A - SCHEDULE 13D FOR THOMAS TAIT Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Nu-Med Plus, Inc. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 67021R 104 (CUSIP Number) Thomas A. Tait 12560 Kaibab Ct. Colorado Springs, CO 80908 (801) 857-4798 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) Sept |
|
| August 13, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission File Number 000-54808 NU-MED PLUS, INC. (Exact name of registrant as speci |
|
| May 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 numedform10qmarch13.htm QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED MARCH 31, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition pe |
|
| March 28, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 [ ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-54808 NU-MED PLUS, I |
|
| February 14, 2013 |
NUMD / Nu-Med Plus Inc. / Moon William G - SCHEDULE 13D FOR WILLIAM MOON Activist Investment SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 14, 2013 |
NUMD / Nu-Med Plus Inc. / Morrison Craig - SCHEDULE 13D FOR DR. CRAIG MORRISON Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Nu-Med Plus, Inc. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 67021R 104 (CUSIP Number) Dr. Craig W. Morrison 975 North Terrace Drive Provo, Utah 84601 (801) 746-3570 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
|
| February 14, 2013 |
NUMD / Nu-Med Plus Inc. / Robins Jeffrey Lynn - SCHEDULE 13D FOR JEFFREY ROBINS Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Nu-Med Plus, Inc. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 67021R 104 (CUSIP Number) Jeffrey L. Robins 2152 W. Bryce Drive Kaysville, Utah 84037 (801) 746-3570 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) Feb |
|
| February 13, 2013 |
SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 NU-MED PLUS, INC. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 67021R 104 (CUSIP Number) February 8, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13 |
|
| February 12, 2013 |
NU-MED PLUS, Inc. 455 E 500 S Suite 205 Salt Lake City, Utah 84111 February 11, 2013 Brian Soares, Esq. Russell Mancuso, Esq. Division of Corporation Finance United States Securities and Exchange Commission Mail Room 4561 100 F. Street, N.E. Washington, D.C. 20549 Re: Nu-Med Plus, Inc. Amendment No. 2 Registration Statement on Form 10 Filed January 29, 2013 File No. 000-54808 Dear Mr. Soares: To a |
|
| February 12, 2013 |
AMENDED AND RESTATED BYLAWS OF NU-MED PLUS, INC. A UTAH CORPORATION TABLE OF CONTENTS ARTICLE PAGE ARTICLE I OFFICES 1 Section 1.1 Business Office 1 Section 1.2 Registered Office 1 ARTICLE II SHAREHOLDERS 1 Section 2.1 Annual Shareholder Meeting 1 Section 2.2 Special Shareholder Meetings 1 Section 2.3 Place of Shareholder Meetings 1 Section 2.4 Notice of Shareholder Meetings 2 Section 2.5 Meetings |
|
| February 12, 2013 |
- THIRD AMENDED REGISTRATION STATEMENT ON FORM 10/A-3 As filed with the Securities and Exchange Commission on February 12, 2013 Registration No. |
|
| January 29, 2013 |
NU-MED PLUS, Inc. 455 E 500 S Suite 205 Salt Lake City, Utah 84111 January 29, 2013 Brian Soares, Esq. Russell Mancuso, Esq. Division of Corporation Finance United States Securities and Exchange Commission Mail Room 4561 100 F. Street, N.E. Washington, D.C. 20549 Re: Nu-Med Plus, Inc. Registration Statement on Form 10 Filed December 10, 2012 File No. 000-54808 Dear Mr. Soares: To assist the staff |
|
| January 29, 2013 |
- SECOND AMENDED REGISTRATION STATEMENT ON FORM 10/A-2 As filed with the Securities and Exchange Commission on January 29, 2013 Registration No. |
|
| January 15, 2013 |
NU-MED PLUS, Inc. 455 E 500 S Suite 205 Salt Lake City, Utah 84111 January 15, 2013 Brian Soares, Esq. Russell Mancuso, Esq. Division of Corporation Finance United States Securities and Exchange Commission Mail Room 4561 100 F. Street, N.E. Washington, D.C. 20549 Re: Nu-Med Plus, Inc. Registration Statement on Form 10 Filed December 10, 2012 File No. 000-54808 Dear Mr. Soares: To assist the staff |
|
| January 15, 2013 |
- AMENDED REGISTRATION STATEMENT ON FORM 10/A As filed with the Securities and Exchange Commission on January15, 2013 Registration No. |
|
| December 14, 2012 |
NU-MED PLUS, Inc NU-MED PLUS, Inc. 455 E 500 S Suite 205 Salt Lake City, Utah 84111 December 12, 2012 Brian Soares, Esq. Russell Mancuso, Esq. Division of Corporation Finance United States Securities and Exchange Commission Mail Room 4561 100 F. Street, N.E. Washington, D.C. 20549 Re: Nu-Med Plus, Inc. Registration Statement on Form 10 Filed September 20, 2012 File No. 000-54808 Dear Mr. Soares: N |
|
| December 10, 2012 |
$100,000 November 14, 2012 CONVERTIBLE PROMISSORY NOTE The undersigned promises to pay to the order of Smith Corporate Services, Inc. |
|
| December 10, 2012 |
josselyn articles of Inc. ARTICLES OF INCORPORATION OF NU-MED PLUS, INC. The undersigned incorporator, desiring to form a corporation under the laws and constitution of the state of Utah, does hereby sign and deliver, in duplicate, to the Division of Corporations and Commercial Code of the state of Utah these Articles of Incorporation for NU-MED PLUS, INC. (hereinafter referred to as the "Corporat |
|
| December 10, 2012 |
EX-10 7 scscontractnumed5.htm CONSULTING CONTRACT - SCS CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this "Agreement") is entered into effective the 1st day of April 2012, and entered into this 14th day of November, 2012, by and between Nu-Med Plus, Inc., a Utah corporation (the "Company"), and Smith Corporate Services, Inc., a Utah corporation (the "Consultant"). WHEREAS, Consultant has been a |
|
| December 10, 2012 |
- FORM 10 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on December 7, 2012 Registration No. |
|
| December 10, 2012 |
Converted by EDGARwiz |
|
| December 10, 2012 |
CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is entered into effective as of the 1st day of November, 2012, by and between NU-MED PLUS, INC. |
|
| December 10, 2012 |
BYLAWS NU-MED PLUS, INC. A UTAH CORPORATION TABLE OF CONTENTS EX-3 3 utahbylawsnewmed.htm BY-LAWS OF NU-MED BYLAWS OF NU-MED PLUS, INC. A UTAH CORPORATION TABLE OF CONTENTS ARTICLE PAGE ARTICLE I OFFICES 1 Section 1.1 Business Office Section 1.2 Registered Office 1 1 ARTICLE II SHAREHOLDERS 1 Section 2.1 Annual Shareholder Meeting 1 Section 2.2 Special Shareholder Meetings 1 Section 2.3 Place of Shareholder Meetings 1 Section 2.4 Notice of Shareholder Meetin |
|
| December 10, 2012 |
CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is entered into effective as of the 1st day of November, 2012, by and between NU-MED PLUS, INC. |
|
| December 10, 2012 |
CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is entered into effective as of the 2nd day of November, 2012, by and between NU-MED PLUS, INC. |
|
| November 9, 2012 |
- WITHDRAWAL REQUEST FOR OUR REGISTRATION STATEMENT ON FORM 10 NU-MED PLUS, INC. 455 East 500 South, Suite 205 Salt Lake City, Utah 84111 November 9, 2012 VIA EDGAR TRANSMISSION Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: NU-MED PLUS, INC. Registration Statement on Form 10-SB Filed: September 20, 2012 File No. 000-54808 Ladies and Gentlemen: Pursuant to Rule 477, NU-MED PLUS, INC. (the “Company”) hereby respectfully reques |
|
| September 20, 2012 |
- FORM 10 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on September 20, 2012 Registration No. |
|
| September 20, 2012 |
ARTICLES OF INCORPORATION NU-MED PLUS, INC. josselyn articles of Inc. ARTICLES OF INCORPORATION OF NU-MED PLUS, INC. The undersigned incorporator, desiring to form a corporation under the laws and constitution of the state of Utah, does hereby sign and deliver, in duplicate, to the Division of Corporations and Commercial Code of the state of Utah these Articles of Incorporation for NU-MED PLUS, INC. (hereinafter referred to as the "Corporat |
|
| September 20, 2012 | ||
| September 20, 2012 |
BYLAWS OF NU-MED PLUS, INC. A UTAH CORPORATION TABLE OF CONTENTS ARTICLE PAGE ARTICLE I OFFICES 1 Section 1.1 Business Office Section 1.2 Registered Office 1 1 ARTICLE II SHAREHOLDERS 1 Section 2.1 Annual Shareholder Meeting 1 Section 2.2 Special Shareholder Meetings 1 Section 2.3 Place of Shareholder Meetings 1 Section 2.4 Notice of Shareholder Meetings 2 Section 2.5 Meetings by Telecommunication |
